Quantus

Value Added Technology

A043150 · KOSDAQ
₩17,350+2.06%
2026-08-03 close

Value Added Technology — pricey right now, or cheap? And what signals are flashing today?

Open the exact grade & valuation bands with Pro →
Loading chart…
Close
AI Insight

Why these signals fired — only backtest-proven edge, told honestly

Why this signalSignal guide

Moving-average alignment
No

No active signal.

Explore this stock further
Review signal, financial and filing context in chat
Explore in chat →

Strong-buy signal — the real recordrecord · not a prediction

Not this one stock, but every strong-buy pick we actually published (Korea market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-03)

Last 30 sessions
648 picks
Next-day win rate
49.2%
Avg next-day
-0.17%
vs market
+0.72%p

Beat the market on 62.1% of picks (each pick vs its own day’s market average).

Recent publish days (next-day win rate)
07-31 0%07-30 66.7%07-29 0%07-28 45%07-27 20%07-25 36.4%07-21 55.6%07-20 53.8%07-16 53.3%07-15 50%07-14 71.4%07-13 31.2%
This stock has not flashed this signal recently — the record above is the signal’s own, not this stock’s.

Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.

Valuation Grades

Relative to 295 건강관리 peers · not investment advice

Pro unlocks the composite grade, 5 factors and sector rank · ₩19,900/mo

Valuation in its own history

PER 4.67 · PBR 0.57 — own history (2006-09~) percentiles 96/100 · 100/100

PER96/100
PBR100/100

Higher indicates lower valuation relative to its history (based on earnings and book yields).

Earnings percentiles can fluctuate for cyclical companies (including loss periods), so the book basis is shown alongside. Companies with large share buybacks can have structurally high PBR. Factual information, not investment advice.

Annual dividend

Split-adjusted annual DPS history and available grade axes

Annual dividend per share chart2010: 100원20102011: 150원2012: 100원2013: 100원2014: 100원2015: 100원20152016: 100원2017: 100원2018: 100원2019: 100원2020: 100원20202021: 100원2022: 100원2023: 100원2024: 100원2025: 100원100원2025
Annual dividend (per share · split-adjusted) · as of 2025
Consistency
A-
Growth
C+
Yield
F
Safety
A+
Reference indicatorView observed cut rates

Paid 16 consecutive years · Raised 0 consecutive years · Yield 0.58% (based on 2025 payment of 100원) · 3-year growth +0.0%

Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.

Financial safety

Reference indicatorAs of 2024
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 7.48
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
7.48
Beneish M-Score
-2.31

No statistical flag

Sloan accrual
2.43%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

5/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score5/9

Profitability

  • Positive ROAPass
  • Positive OCFPass
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Not passed

Leverage & liquidity

  • Lower debtPass
  • Higher current ratioPass
  • No new sharesPass

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Revenue qualityWarning

매출채권 증가율이 매출 증가율의 1.5배 초과 (3기 연속) — 매출 인식 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Cash conversion cycleWarning

현금전환주기(CCC) 4기 연속 확대 — 운전자본 경색·현금 회수 지연 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

KRAs of 2026-08-03

건강관리

This stock is in 건강관리: revenue rank 38 of 290, share 0.6%.

38 / 2900.6%revenue share

Who dominates this industry?

  1. 1삼성바이오로직스7.3%
  2. 2셀트리온5.7%
  3. 3녹십자홀딩스3.5%
  4. 4유한양행3.3%
  5. 5대웅3.1%
  6. 6바텍0.6%

Concentration

DistributedCR3 16.6%
HHI 201290 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

Winner-take-all deepeningConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
31.61
Direction
확대
Level
넓음
Years
7

Value lens

P90/P10
14
Median P/B
1.47
Level
넓음
n
269

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
14%
Interest coverage
24.1x
Return on equity (ROE)
12.2%

Operating margin −5pp

Tolerable
Interest coverageBase 24.1x adverse case 15.5x
Return on equity (ROE)Base 12.2% adverse case 7.1%

Revenue −15%

Tolerable
Interest coverageBase 24.1x adverse case 20.5x
Return on equity (ROE)Base 12.2% adverse case 9.6%

Interest rate +2pp

Tolerable
Interest coverageBase 24.1x adverse case 8.7x
Return on equity (ROE)Base 12.2% adverse case 10.5%

Interest coverage limit

Current margin 13.4pp

Interest coverage limit at an operating margin of 0.6%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-18

Suppliers disclosed by the company in its 2026-03-18 annual report.

Purchase amount

KRW 100m
  1. IFRS
    KRW 23.4T
  2. Air
    KRW 14.2T
  3. EzRay
    KRW 14.2T
  4. Digital
    KRW 3.5T
  5. Green
    KRW 3.5T
  6. Smart
    KRW 3.5T
  7. EzSensor
    KRW 2.3T
  8. Tube
    KRW 537.6B
  9. Ass
    KRW 477.9B
  10. Column
    KRW 477.9B

+1 more with disclosed amounts — included in coverage

Suppliers without disclosed amount

바텍세이프온바텍바텍을바텍이우홀딩스로바텍과바텍엠시스를바텍엠시스바텍엠시스가IIIVIIVIIIXII+91 more

Financials at a glance

Value Added Technology's latest results and balance sheet. The bars track the last three periods.

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

  • 피델리티매니지먼트앤리서치컴퍼니엘엘씨7.75%2026-03-10 · 증감 -0.29%p
  • SwedbankRoburFonderAB5.05%2025-07-23 · 증감 +0.07%p

Other stocks held by the same investors

A filing-based shared-holder record, not investment advice.

Connections

AI-extracted related companies · for reference

Suppliers
Ge HealthCare
Customers
Henry ScheinPatterson Companies
Competitors
덴티움Price comovement r=0.36 (1 year)신흥솔메딕스Carestream DentalPlanmecaDentsply Sirona
Same theme
Align Technology3D SystemsVatech C&C
🔗 See in the full market map →

Recent filings

Value Added Technology's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

Signal history (last ~2 years)

Every occurrence on this stock, with the return 20 trading days later. Small sample — a record, not a prediction.

Golden cross×1
26-04-01+4%
New MA alignment×2
26-04-27-17.6%26-04-14-3.2%

“·” = fewer than 20 trading days since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.

Like these rules? Run them automatically.

Quantus turns rules like these into backtests and automated trading — same team, free to start.

Quantus Signal · live data · not investment advice · Privacy Policy